Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid: Repression of IFN-γ-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway

Journal of Immunology

Volumn 156, Issue 4, 1996, Pages 1601-1608

  Tanaka, Hirotoshi ^a   Makino, Yuichi ^a   Miura, Takanori ^a   Hirano, Fuminori ^a   Okamoto, Kensaku ^a   Komura, Keiji ^a   Sato, Yoichi ^a,b   Makino, Isao ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; URSODEOXYCHOLIC ACID;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CHO CELL; DRUG RECEPTOR BINDING; DRUG THERAPY; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; IMMUNOSTIMULATION; LIGAND BINDING; LIVER DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BASE SEQUENCE; CELL COMPARTMENTATION; CHO CELLS; CRICETINAE; DEXAMETHASONE; DNA-BINDING PROTEINS; DOWN-REGULATION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; GLUCOCORTICOIDS; INTERFERON TYPE II; LIGANDS; MOLECULAR SEQUENCE DATA; RECEPTORS, GLUCOCORTICOID; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; URSODEOXYCHOLIC ACID;

EID: 0030043423     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Nakagawa, S , I. Makino, T Ishizaki, and I. Dohi. 1977. Dissolution of cholesterol gall stones after treatment with ursodeoxycholic acid Lancet 2:367.
2. Leuschner, U., H Fischer, W. Kurtz, S. Guldutuna, K. Hubner, A Hellstern, M. Galzea, and M. Leuschner 1989 Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial Gastroenterology 97:1268.
3. Poupon, R. E., B. Balkau, E Eschwege, R Poupon, and The UDCA-PBC Study Group. 1991. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis N. Engl. J. Med. 324:1548
4. Poupon, R, E., R Poupon, B. Balkau, and The UDCA-PBC Study Group. 1994. Ursodiol for the long-term treatment of primary biliary cirrhosis N. Engl. J Med. 330:1342.
5. Lindor, K. D., E. R. Dickson, W. P. Baldus, R. A. Jorgensen, J. Ludwig, P. A. Murtaugh, J. M. Harrison, et al. 1994. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 106:1284.
6. Heathcote, E. J., K. Cauch-Dudek, V. Walker, R. J. Bailey, L. M. Blendis, C. N. Ghent, P. Michieletti, et al. 1994. The Canadian muiticenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 19:1149.
7. O'Brien, C., J. R. Senior, R. Arora-Mirchandani, A. K. Batta, and G. Salen. 1991. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology 14:838
8. Takano, S . Y. Ito, O. Yokosuka, M Ohto, K Uchiumi, K. Hirota, and M. Omata. 1994. A muiticenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C. Hepatology 20:558
9. Cirillo, N. W., and F. R. Zwas. 1994. Ursodeoxycholic acid in the treatment of chronic liver disease. Am J. Gastroenterol. 89:1447.
10. Coleman, R., S. Iqbal, P. P. Godfrey, and D. Billington. 1979. Composition of several mammalian biles and their membrane-damaging properties. Biochem. J. 178:201.
11. Heuman, D. M., W. M Pandak, P. B. Hylemon, and Z. R. Vlahcevic 1991 Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 14:920.
12. Calmus, Y , P. Gane, P. Rouger, and R. Poupon 1990. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis, effect of ursodeoxycholic acid. Hepatology 11:12
13. Yoshikawa, M., T. Tsujii, K. Matsumura, J. Yamao, Y. Matsumura, R. Kubo, H Fukui, and S. Ishizaka. 1992. Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 16:358.
14. Calmus, Y , J. Guechot, P Podevin, M.-T Bonnefis, J. Giboudeau, and R. Poupon. 1992. Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6, and tumor necrosis factor-α production by monocytes. Hepatology 16:719
15. Lacaille, F , and K, Paradis 1993. The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells Hepatology 18:165.
16. Calmus, Y , B. Weill, Y. Ozier, C Chereau, D. Houssin, and R Poupon. 1992. Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse. Gastroenterology 103:617.
17. Boumpas, D. T., F. Paliogianni, E. D. Anastassiou, and J. E. Balow. 1991. Glucocorticoid action on the immune system: molecular and cellular aspects. Clin. Exp. Rheumatol. 9:413.
18. Evans, R. M. 1988. The steroid and thyroid hormone receptor super family Science 240:889
19. Beato, M. 1989 Gene regulation by steroid hormones. Cell 56:335.
20. Beato. M. 1991 Transcriptional control of nuclear receptors FASEB J. 5:2044.
21. Schule, R , and R M Evans 1991. Cross-coupling of signal transduction pathways: zing finger meets leucine zipper Trends Genet 7:377.
22. Pfahl, M. 1993. Nuclear receptor/AP-1 interaction. Endocr. Rev. 14:651
23. Pratt, W. B. 1993 The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J. Biol. Chem. 268:21455.
24. Smith, D. F., and D. O. Toft. 1993. Steroid receptors and their associated proteins. Mol. Endocrinol. 7:4.
25. Tanaka, H., and I Makino 1992. Ursodeoxycholic acid-dependent activation of the glucocorticoid receptor. Biochem. Biophys Res. Commun. 188:942.
26. Alksnis, M , T. Barkhem, P.-E Strömstedt, H. Ahola, E. Kutoh, J.-Å. Gustafsson, L Poellinger, and S Nilsson. 1991 High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells. J. Biol Chem 266:10078.
27. Cidlowski, J. A., D L Bellingham, F. E Powell-Ohver, D B. Lubahn, and M Sar 1990. Novel antipeptide antibodies to the human glucocorticoid receptor: recognition of multiple forms in vitro and distinct localization of cytoplasmic and nuclear receptors. Mol. Endocrinol. 4:1427
28. Dignam, D. J., R. M. Lebovitz, and R. G. Roeder 1983. Accurate transcription initiation by RNA polymerase II in soluble extract from isolated mammalian nuclei Nucleic Acid Res. 11:1475
29. Makino, Y., H. Tanaka, and I. Makino. 1994. Paradoxical derepression of glucocorticoid receptor function by the anti-rheumatic compound aurothiomalate. Mol. Pharmacol 46:1084
30. Tsai, S Y, M.-J Tsai, and B. M O'Malley. 1989. Cooperative binding of steroid hormone receptors contributes to transcriptional synergism at target enhancer elements. Cell 57:361
31. Rangarajan, P N , K Umezono, and R. M. Evans 1992. Modulation of glucocorticoid receptor by protein kinase A Mol. Endocrinol. 6:26.
32. Panek, R. B , H Moses, J. P-Y. Ying, and E. N Benveniste 1992. Tumor necrosis factor a response elements in the HLA-DRA promoter: identification of a tumor necrosis factor α-induced DNA-protein complex in astrocytes Proc. Natl. Acad. Sci. USA 89:11518.
33. 33: Hirano, F., H. Tanaka, H., and I. Makino. 1993. Chenodeoxycholic acid-dependent induction of major histocompatibility complex class I mRNA expression in a human hepatoma cell line. Biophys. Biochem. Res. Commun. 195:1408.
34. Inoko, H., A Ando, M Kimura, and K. Tsuji 1985 Isolation and characterization of the cDNA clones and genomic clones of the HLA class II antigens In Proceedings of the Twentieth Annual Meeting of the Japane Society for Transplantation K. Tsuji, ed Tokai University Press, Tokyo, p. 188
35. Cleveland, D. W., M. A. Lopata, R. H MacDonald, N J Cowan, W. S. Rutter, and M. W. Kirschner 1980. Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and r- actin genes using specific cloned cDNA probes. Cell 20:95.
36. Martins, V. R., W. B. Pratt, L. Terracio, M. A. Hirst, G. M Ringold, and P. R. Housley. 1991. Demonstration by confocal microscopy that unliganded overexpressed glucocorticoid receptors are distributed in a nonrandom manner throughout all planes of the nucleus. Mol. Endocrinol 5:217
37. Harmon, J. M., H. J. Eisen, S. T. Brower, S. S. Simons Jr., C. L Langley, and E. B. Thompson 1984. Identification of human leukemic glucocorticoid receptors using affinity labeling and anti-human glucocorticoid receptor antibodies. Cancer Res. 44:4540.
38. Fertsch, D., D. R. Schoenberg, R N. Germain, J. Y. L. Tou, and S. N. Vogel. 1987. Induction of macrophage la antigen expression by rIFN-γ and down-regulation by IFN-α/β and dexamethasone are mediated by changes in steady-state levels of Ia mRNA. J. Immunol. 139:244.
39. Celada, A., S. McKercher, and R. A. Maki. 1993 Repression of major histocompatibility complex 1A expression by glucocorticoids: the glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein. J Exp Med. 177:691.
40. Fujita, T., H. Shibuya, T. Ohashi, K. Kamanishi, and T. Taniguchi. 1986. Regulation of human interleukIN-2 gene: functional DNA sequences in the 5′ flanking region for the gene expression in activated T lymphocytes. Cell 46:401.
41. Northrop, J P., G R. Crabtree, and P. S. Mattila. 1992. Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J. Exp Med. 175:1235
42. Paliogiani, F., A. Raptis, S. S. Ahuja, S. M Najjar, and D. T. Boumpas. 1993. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-I and NF-AT. J. Clin. Invest. 91:1481.
43. Atchison, M. L , and R. P. Perry. 1987. The role of the k enhancer and its binding factor NF-κB m the developmental regulation of κ gene transcription. Cell 48: 121
44. Mukaida, N., M. Morita, Y. Ishikawa, N. Rice, S. Okamoto, T. Kasahara, and K. Matsushima. 1994 Novel mechanism of glucocorticoid-mediated gene repression. J. Biol. Chem. 269:13289
45. Roy, A., and K. E. Prefontaine. 1994 Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl Acad Sci USA 91:7524.
46. Scheinman, R I , A. Gualberto, C. M Jewell, J. A. Cidlowski, and A. S. Baldwin Jr. 1995. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors Mol Cell. Biol 15:943.
47. 2+ release from permialized liver cells and liver microsomes. J. Biol. Chem. 264:157.
48. Quist, R G., H.-T Ton-Nu, J. Lillenau, A. F Hofmann, and K. E. Barrett. 1991. Activation of mast cells by bile acids. Gastroenterology 101:446.
49. Sanchez, E R., J.-L. Hu, S. Zhong, P. Shen, M. J. Grcene, and P. R. Housley 1994 Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock Mol Endocrinol. 8:408.
50. Somers, J. P., and D. B. DeFranco. 1992. Effects of okadaic acid, a protein phosphatase inhibitor, on glucocorticoid receptor-mediated enhancement. Mol. Endocrinol 6:26.
51. DeFrance, D B., M. Qi, K. C. Borror, M. J. Garabedian, and D. L. Brautigan. 1991. Protein phosphatase type I and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors Mol. Endocrinol 5:1215.
52. Gradin, K., M. L Whitelaw, R. Toftgård, L. Poellinger, and A. Berghard. 1994 A tyrosine kinase-dependent pathway regulates ligand-dependent activation of the dixin receptor in human keratinocytes. J. Biol. Chem 269:23800
53. Ning, Y.-M., and E R Sanchez. 1993. Potentiation of glucocorticoid-mediated gene expression by the immunophilin ligands FK506 and rapamycin J. Biol. Chem. 268:6073.
54. Tai, P.-K, K., M. W. Albers, H Chang, L. E. Faber, and S. L. Schreiber 1992. Association of a 59-kilodalton immunophilin with the glucocorticoid receptor Science 256:1315.
55. Hu, J.-M., J. E. Bodwell, and A. Munck. 1994. Cell cycle-dependent glucocorticoid receptor phosphorylation and activity. Mol. Endocrinol. 8:1709.
56. Hsu, S.-C., and D B. DeFrance. 1995. Selectivity of cell cycle regulation of glucocorticoid receptor function. J. Biol. Chem. 270:3359.
57. Hu, L -M, J. Bodwell, J M. Hu, E. Orti, and A. Munck. 1994. Glucocorticoid receptors in ATP-depleted cells. J. Biol. Chem. 269:6571.
58. Willman, T., and M. Beato. 1986. Steroid-free glucocorticoid receptor binds specifically to mouse mammary tumor virus DNA. Nature 324:688.
59. Giguere, V., S. M Hollenberg, M. G. Rosenfeld, and R. M. Evans 1986. Functional domains of the human glucocorticoid receptor. Cell 46:645.
60. Lanz, R. B., M. Hug, M. Gola, T. Tallone, S. Wieland, and S. Rusconi 1994. Active, interactive and inactive steroid receptor mutants Steroids 59:148.
61. Danielian, P. S , R. White, J. A. Lees, and M. G. Parker. 1992. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025.
62. Vegeto, E , G. F. Allan, W. T. Schrader, M.-J. Tsai, D P. McDonnel, and B W O'Malley 1992. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor Cell 69:703
63. Nezu, N., K. Ryu, Y Koide, and T. O. Yoshida. 1990 Regulation of HLA. class II molecule expressions by IFN-γ. J. Immunol. 145:3126.
64. Caldenhoven, E., J Linden, S. Wissink, A Van de Stolpe, J. Raaijimakers, L Koenderman, S Okret, J.-Å Gustafsson, and P. T. Van der Saag 1995 Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9:401.
65. Jonat, C., H. J. Rahmsdorf, K.-K. Park, A. C B. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone Cell 62:1189.
66. Helmberg, A., N. Auphan, C Caelles, and M. Karin. 1995. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 14:452.
67. Steimle, V., C.-A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by transactivation gene CIITA. Science 265:106.
68. Heck, S., M. Kullmann, A. Gast, H. Ponta, H. J. Rahmsdorf, P. Herrlich, and A. C. B Cato. 1994. A distinct modulating domain in glucocorticoid receptor monomers in the repression activity of the transcription factor AP-1. EMBO J. 13:4087